170 related articles for article (PubMed ID: 16218880)
21. [The best of vascular medicine in 2006].
Mounier-Vehier C; Stephan D; Aboyans V; Beregi JP; Lacroix P; Léger P; Long A; Sevestre MA;
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
[TBL] [Abstract][Full Text] [Related]
22. Re: Secondary medical prevention in patients with peripheral arterial disease.
Schouten O; Welten GM; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
[No Abstract] [Full Text] [Related]
23. Peripheral arterial disease: a review of disease awareness and management.
Watson K; Watson BD; Pater KS
Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
[TBL] [Abstract][Full Text] [Related]
24. [Antiplatelet therapy in patients with peripheral arterial disease (PAD)].
Diehm C; Lawall H; Huber R
Med Klin (Munich); 2004 Aug; 99 Suppl 1():14-20. PubMed ID: 15487853
[TBL] [Abstract][Full Text] [Related]
25. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
Beckman JA; Paneni F; Cosentino F; Creager MA
Eur Heart J; 2013 Aug; 34(31):2444-52. PubMed ID: 23625211
[TBL] [Abstract][Full Text] [Related]
26. Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality.
Daskalopoulou SS; Daskalopoulos ME; Liapis CD; Mikhailidis DP
Curr Med Chem; 2005; 12(4):443-52. PubMed ID: 15720252
[TBL] [Abstract][Full Text] [Related]
27. Comparison of cardiovascular risk factors and drug use in 14,544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease.
Bongard V; Cambou JP; Lezorovcz A; Ferrères J; Vahanan A; Jullen G; Coppe G; Guerllot M; Herrmann MA; Mas JL
Eur J Cardiovasc Prev Rehabil; 2004 Oct; 11(5):394-402. PubMed ID: 15616412
[TBL] [Abstract][Full Text] [Related]
28. Rationale for the use of platelet aggregation inhibitors in PAD patients.
Agnelli G
Vasc Med; 2001; 6(3 Suppl):13-5. PubMed ID: 11789961
[TBL] [Abstract][Full Text] [Related]
29. [Cardiovascular prevention with peripheral artery disease].
Vértes A
Orv Hetil; 2007 Jul; 148(28):1303-9. PubMed ID: 17611180
[TBL] [Abstract][Full Text] [Related]
30. [Cardiovascular event in elderly patients with diabetes mellitus].
Nomura K
Nihon Rinsho; 2013 Nov; 71(11):1954-9. PubMed ID: 24397165
[TBL] [Abstract][Full Text] [Related]
31. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.
Sabouret P; Cacoub P; Dallongeville J; Krempf M; Mas JL; Pinel JF; Priollet P; Steg G; Taminau D; Montalescot G;
Arch Cardiovasc Dis; 2008 Feb; 101(2):81-8. PubMed ID: 18398391
[TBL] [Abstract][Full Text] [Related]
32. Hypertension in peripheral arterial disease.
Clement DL; De Buyzere ML; Duprez DA
Curr Pharm Des; 2004; 10(29):3615-20. PubMed ID: 15579058
[TBL] [Abstract][Full Text] [Related]
33. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
34. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
Hiatt WR; Krantz MJ
Vasc Med; 2006 Feb; 11(1):55-60. PubMed ID: 16669416
[TBL] [Abstract][Full Text] [Related]
35. Antithrombotic therapy in peripheral arterial occlusive disease.
Jackson MR; Clagett GP
Chest; 1998 Nov; 114(5 Suppl):666S-682S. PubMed ID: 9822070
[No Abstract] [Full Text] [Related]
36. Lipid-lowering therapy in patients with peripheral arterial disease.
Ebrahimi R; Saleh JR; Toggart EJ; Hayatdavoudi B; Wolf CJ; Wadhani NN; Shah AP
J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):271-7. PubMed ID: 15678246
[TBL] [Abstract][Full Text] [Related]
37. Medical management for chronic atherosclerotic peripheral arterial disease.
Ali FN; Carman TL
Drugs; 2012 Nov; 72(16):2073-85. PubMed ID: 23046179
[TBL] [Abstract][Full Text] [Related]
38. Medical treatment of peripheral arterial disease.
Hankey GJ; Norman PE; Eikelboom JW
JAMA; 2006 Feb; 295(5):547-53. PubMed ID: 16449620
[TBL] [Abstract][Full Text] [Related]
39. What's new in type 2 diabetes?
McCarthy JC; Pearson RD
J Fam Pract; 2012 Nov; 61(11):646-51. PubMed ID: 23256094
[TBL] [Abstract][Full Text] [Related]
40. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study.
Blacher J; Cacoub P; Luizy F; Mourad JJ; Levesque H; Benelbaz J; Michon P; Herrmann MA; Priollet P
J Vasc Surg; 2006 Aug; 44(2):314-8. PubMed ID: 16890860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
